Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Quercetin Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 9 0
Myricetin Potential treatment - theoretical effect Natural product Antiviral Dec/28/2020 4 0
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/11/2020 3 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 6 1
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/24/2020 3 0
Entrectinib Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/21/2020 2 0
Radotinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Tivantinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Lifirafenib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0